Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (ARG506 → Gln) in the factor V gen (factor V Leiden)

Journal of Clinical Gastroenterology

Volumn 27, Issue 4, 1998, Pages 361-363

  Pinar A ^a   Saenz, R ^a   Rebollo, J ^a   Gomez Parra, M ^a   Carrasco, F ^a   Herrerias, J M ^a   Jimenez Saenz, M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Factor V Leiden; Heterozygous; Portal thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTICOAGULANT PROTEIN; ARGININE; BLOOD CLOTTING FACTOR 5 LEIDEN; GLUTAMINE; PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AMINO ACID SUBSTITUTION; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MESENTERIC VEIN THROMBOSIS; ORAL DRUG ADMINISTRATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

ADULT; ARGININE; DIAGNOSIS, DIFFERENTIAL; FACTOR V; GLUTAMINE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MESENTERIC VEINS; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 0031734472     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199812000-00019     Document Type: Article

References (19)

1. Mitchell MC, Boinott JK, Kaufman S, et al. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 1982;61:199-218.
2. Cardin F, Graffeo M, McCormick PA, et al. Adult "idiopathic" extrahepatic venous thrombosis. Importance of putative "latent" myeloproliferative disorders and comparison with cases with known etiology. Dig Dis Sci 1992;37:335-9.
3. Valla D, Casadevall N, Huisse MG, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 1988;94:1063-9.
4. Prat F, Ouzan D, Trecziak N, et al. Portal and mesenteric thrombosis revealing constitutional protein C deficiency. Gut 1989;30:416.
5. Sas G. Blaskó G, Petr I, et al. A protein S deficient family with portal vein thrombosis. Thromb Haemost 1985;54:724.
6. Wilson C, Walker ID, Davidson JF, et al. Mesenteric venous thrombosis and antithrombin III deficiency. J Clin Pathol 1987; 40:906-8.
7. Pabinger I, Brucker S, Kyrle PA, et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coag Fibrinol 1992;3:547-53.
8. Griffin JH, Evatt B, Wideman C, et al. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989-93.
9. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
10. 506 of factor V. Lancet 1994;343:1535-6.
11. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994;343:1536-8.
12. Simioni P, Prandoni P, Lensing AWA, et al. The risk of recurrent venous thromboembolism in patients with an Arg506-Gln mutation in the gene for factor V (Factor Leiden). N Engl J Med 1997;336:399-403.
13. Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and Factor V leiden. Effect on thrombosis. N Engl J Med 1996;334:763-8.
14. Vandenbroucke JP, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-7.
15. Koeleman BP, Reitsma PH, Allaart CF, et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994;84:1031-5.
16. Van Boven HH, Reitsma PH, Rosendaal FR, et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996;75:417-21.
17. Levoir D, Aubertine JM, Almenc-Gelas M, et al. Une nouvelle cause hereditaire de thrombose portale:la resistance anormale a la proteine C activée par mutation Arg506-Gln du gene du facteur V. Gastroenterol Clin Biol 1995;19:729-31.
18. Fickert P, Ramschak H, Kenner L, et al. Acute Budd-Chiari syndrome with fulminant hepatic failure in pregnant woman with factor V Leiden mutation. Gastroenterology 1996;111:1670-3.
19. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.